RHY rhythm biosciences limited

A closer look at the credentials of CEO Dr David Atkins’s and...

  1. 362 Posts.
    lightbulb Created with Sketch. 113
    A closer look at the credentials of CEO Dr David Atkins’s and Non-Executive Director Gavin Fox-Smith is also important when determine the value of this company.

    Atkins was 22 years in senior roles with Johnson and Johnson, UK and US based.

    Fox- Smith was 22 years in senior roles with Johnson and Johnson Medical Devices Australia/NZ. He is currently Non-Executive Director of Bowel Cancer Australia.

    They are both older experienced leaders, with vast professional credentials, and just about as well connected as possible!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
6.0¢
Change
0.000(0.00%)
Mkt cap ! $17.04M
Open High Low Value Volume
5.9¢ 6.1¢ 5.9¢ $32.27K 533.7K

Buyers (Bids)

No. Vol. Price($)
1 500 5.6¢
 

Sellers (Offers)

Price($) Vol. No.
6.0¢ 11284 1
View Market Depth
Last trade - 15.03pm 01/08/2025 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.